Over the last 6 9 months the FDA has issued over 75 Warning or Untitled letters that target company promotional activities related to misleading efficacy/safety claims, inadequate risk information (fair balance), distracting visuals/music in DTC broadcast ads, unsupported superiority claims, and failure to submit materials as required under form 2253
Method-of-Use Patents : These cover the specific therapeutic indications (obesity vs
Research from the American Diabetes Association shows that GLP-1 medications can increase the risk of muscle loss, and patients are often advised to consume more protein to preserve muscle
Where to book Available at six of our UK clinics
However, most of the time, my patients are unaware they have been exposed to mold until they get tested
Anyhoo, liked it, laughed several times, and am re-re-re reminded to quit sugar AGAIN